Further, in a clinical study, a pro-tumorigenic affect of MM derived Galectin-1 was observed on the expansion of M-MDSCs with CD304 interaction, thereby facilitating MM progression following autologous stem cell transplant (ASCT) (Lim et al., 2021). The gene discussed is NRP1; the disease is Miyoshi myopathy.